"Moreover, the three distributors who previously supplied us with raw materials now all refuse to supply us."
"Without raw materials, we can't produce new drugs, and although we still have some stock, we can only sell it at a reduced price and at a loss. If this continues, the company's cash flow will break, and once the cash flow breaks, that would be..."
At this point, Li Lang stopped and sighed heavily.
Li Qianfan nodded and said, "So, our company is currently facing three problems. The first is the joint suppression by Qian's Pharmaceutical Group and other pharmaceutical companies, who wage a commercial battle by lowering drug prices."
"The second is the refusal of suppliers to supply, leading to insufficient raw material reserves."
"The third is a shortage of funds."
Hearing Li Qianfan's words, Li Lang immediately nodded.